Omega-3 fatty acids in major depressive disorder

European Neuropsychopharmacology - Tập 13 - Trang 267-271 - 2003
Kuan-Pin Su1, Shih-Yi Huang2, Chih-Chiang Chiu2,3, Winston W. Shen4
1Department of Psychiatry, China Medical College Hospital, No. 2, Yuh-Der Road, Taichung 404, Taiwan
2Graduate Institute of Nutrition and Health Sciences, Taipei, Taiwan
3Laboratory of Biological Psychiatry, Taipei City Psychiatric Center, Taipei, Taiwan
4Department of Psychiatry, Taipei Medical University Wan Fang Hospital, School of Medicine, and Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan

Tài liệu tham khảo

Adams, 1996, Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression, Lipids, 31, S157, 10.1007/BF02637069

2000, Practice guideline for the treatment of patients with major depressive disorder (revision), Am. J. Psychiatry, 157, 1

Chiu, 2003, Polyunsaturated fatty acid deficit in patients with bipolar mania, Eur. Neuropsychopharm., 13, 99, 10.1016/S0924-977X(02)00130-X

Chiu, 2003, Omega-3 fatty acid monotherapy for a pregnant patient with major depressive disorder, Am. J. Psychiatry, 160, 385, 10.1176/appi.ajp.160.2.385

Delion, 1994, Chronic dietary alpha-linolenic acid deficiency alters dopaminergic and serotonergic neurotransmission in rats, J. Nutr., 124, 2466, 10.1093/jn/124.12.2466

Delion, 1996, Alpha-linolenic acid deficiency alters age-related changes of dopaminergic and serotonergic neurotransmission in the rat frontal cortex, J. Neurochem., 66, 1582, 10.1046/j.1471-4159.1996.66041582.x

Edwards, 1998, Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients, J. Affect. Disord., 48, 149, 10.1016/S0165-0327(97)00166-3

Emsley, 2002, Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia, Am. J. Psychiatry, 159, 1596, 10.1176/appi.ajp.159.9.1596

Fenton, 2001, A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia, Am. J. Psychiatry, 158, 2071, 10.1176/appi.ajp.158.12.2071

Hibbeln, 1998, Fish consumption and major depression, Lancet, 351, 1213, 10.1016/S0140-6736(05)79168-6

Hibbeln, 1998, A replication study of violent and nonviolent subjects: cerebrospinal fluid metabolites of serotonin and dopamine are predicted by plasma essential fatty acids, Biol. Psychiatry, 44, 243, 10.1016/S0006-3223(98)00143-7

Maes, 1995, The serotonin hypothesis of major depression, 933

Maes, 1996, Fatty acid composition in major depression: decreased omega three fractions in cholesteryl esters and increased C20: 4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids, J. Affect. Disord., 38, 35, 10.1016/0165-0327(95)00092-5

Maes, 1999, Lowered omega-3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients, Psychiatr. Res., 85, 275, 10.1016/S0165-1781(99)00014-1

Marangell, 2000, A double blind, placebo-controlled study of docosahexaenoic acid in the treatment of depression [abstract], Inform., 11, S78

Nemets, 2002, Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder, Am. J. Psychiatry, 159, 477, 10.1176/appi.ajp.159.3.477

Peet, 1998, Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients, Biol. Psychiatry, 43, 315, 10.1016/S0006-3223(97)00206-0

Peet, 2002, A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms, J. Psychiatr. Res., 36, 7, 10.1016/S0022-3956(01)00048-6

Peet, 2002, A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs, Arch. Gen. Psychiatry, 59, 913, 10.1001/archpsyc.59.10.913

Puri, 2002, Eicosapentaenoic acid in treatment-resistant depression, Arch. Gen. Psychiatry, 59, 91, 10.1001/archpsyc.59.1.91-a

Rapoport, 2002, Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder?, Arch. Gen. Psychiatry, 59, 592, 10.1001/archpsyc.59.7.592

Stoll, 1999, Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial, Arch. Gen. Psychiatry, 56, 407, 10.1001/archpsyc.56.5.407

Su, 2000, Is omega 3 fatty acids beneficial in depression but not mania?, Arch. Gen. Psychiatry, 57, 716, 10.1001/archpsyc.57.7.716

Su, 2001, Omega-3 fatty acids as a psychotherapeutic agent for a pregnant schizophrenic patient, Eur. Neuropsychopharm., 11, 295, 10.1016/S0924-977X(01)00098-0

Tanskanen, 2001, Fish consumption, depression, and suicidality in a general population, Arch. Gen. Psychiatry, 58, 512, 10.1001/archpsyc.58.5.512

Weissman, 1996, Cross-national epidemiology of major depression and bipolar disorder, J. Am. Med. Assoc., 276, 293, 10.1001/jama.276.4.293